NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Newmont Corporation (NYSE:NEM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/newmont-corporation-lawsuit-submission-form?prid=128752&wire=1 or contact Joseph E. Levi, Esq.

BELVIDERE, NJ, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced the successful completion of its pilot production of Squeezables - a new line of shelf-stable, stir in paste herbs designed to revolutionize the fresh condiments category – paving the way for a full-scale ramp-up. This innovation enhances the way consumers experience herbs and condiments, providing a longer shelf life, bold fresh flavor, and a fully recyclable packaging solution that aligns with Edible Garden's …

ATLANTA, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of disruptive, accessible in-office therapeutic and diagnostic products, announces the receipt of the Medicines & Healthcare products Regulatory Agency (MHRA) approvals for the FemaSeed® Intratubal Insemination product for female infertility treatment and two diagnostic devices, FemVue® for tubal evaluation and FemCerv® for cervical cancer detection. “This is another key milestone as we expand our reach to the UK following successful approval across Europe for our innovative infertility and cancer detection products.

Best-selling personal emergency response device is newly enhanced with fall detection, and a modern, sleek design Best-selling personal emergency response device is newly enhanced with fall detection, and a modern, sleek design

Shopify's stock has been choppy following a mixed batch of guidance for the current quarter. Is the forecast conservative?

Gold markets had a wild ride throughout the Asian session, initially shooting to the $2940 region, before breaking back below the $2900 level.

ENS, PCRX, CLS and ENVA are four stocks with explosive relative price strength.

SAN DIEGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- LPL Financial LLC announced today that financial advisors Carmen M. Lex Jr., CFP®, RICP®, and Chris Lex, CRPC®, have joined LPL Financial's broker-dealer, Registered Investment Advisor (RIA) and custodial platforms. The brothers reported serving approximately $630 million in advisory, brokerage and retirement plan assets* and join LPL from Corebridge Financial, formerly Valic, a subsidiary of AIG.

EMERYVILLE, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today announced that Brian C. Thomas, PhD, CEO and founder of Metagenomi, will participate in a fireside chat at TD Cowen's 45th Annual Health Care Conference on Wednesday, March 5, 2025, from 1:10-1:40 p.m. ET in Boston. The company will host one-on-one investor meetings at the conference.

Highlights Need to Streamline Portfolio, Improve Operating Performance and Enhance Oversight Discloses a More Than $2.5 Billion Position Full Letter and Presentation Available at Streamline66.com WEST PALM BEACH, Fla. , Feb. 11, 2025 /PRNewswire/ -- Elliott Investment Management L.P.

The US indices that I follow here at FX Empire are all a bit sluggish in the premarket trading, as traders await the testimony of Jerome Powell in front of the US Senate today.

Secures Option to Acquire Full Ownership SANTA FE, NM / ACCESS Newswire / February 11, 2025 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip" or the "Company"), a leading travel technology company, today announced it has closed its previously announced acquisition of a 49% stake in Five Star Alliance, a premier luxury travel agency. As part of the transaction, NextTrip has secured an option to acquire full ownership of Five Star on or before April 7, 2025, subject to certain conditions.

PARIS & NEW YORK & SINGAPORE--(BUSINESS WIRE)--AMTD Group Inc. ("AMTD" or the "Group"), alongside World Media and Entertainment Universal Inc. ("WME"), a subsidiary of the Group under AMTD Digital, jointly announced that as a global owner of fashion magazines published under "L'OFFICIEL" and its associated brands, we have won a successful action in the Hong Kong courts against Luxury Village LLC and its director Dimitri Vorontsov (the "Defendants") for their infringement of "L'OFFICIEL" related.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

There has been a new wave of volatility in the stock market lately, this time due to President Trump's rollout of trade tariffs. This economic uncertainty has led investors to shift their portfolios, seeking safety and additional upside for the coming months.

Humana (HUM) came out with a quarterly loss of $2.16 per share versus the Zacks Consensus Estimate of a loss of $2.26. This compares to loss of $0.11 per share a year ago.

Global investment management firm modernizing investor relations with AI-powered fundraising solutions Global investment management firm modernizing investor relations with AI-powered fundraising solutions

President Trump declared a national energy emergency, expediting energy infrastructure projects to support increased electricity demand from AI, EVs, and electrification. Vistra Corp. is positioned to benefit from the energy crisis. Key growth drivers include AI and EV demand, though challenges like the outdated US electric grid and regulatory uncertainty remain.

Continues Momentum with Deployment of Fully Autonomous AI-Powered Commercial Cleaning Robots Continues Momentum with Deployment of Fully Autonomous AI-Powered Commercial Cleaning Robots

Tom Equels, CEO of AIM ImmunoTech and Professor Casper H.J. van Eijck, MD, PhD, Pancreato-biliary Surgeon at Erasmus MC, discuss the Phase 1b/2 clinical trial involving AIM's Ampligen® (rintatolimod) and AstraZeneca's anti-PD-L1 immune checkpoint inhibitor Imfinzi® (durvalumab) in the treatment of late-stage pancreatic cancer (“DURIPANC”) Watch the “What This Means” segment here